Welcome
Support Centre
21 November 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The FAB Study: Feedback, Awareness and Behaviour in the Fenland Study
ISRCTN ISRCTN92551397
ClinicalTrials.gov identifier
Public title The FAB Study: Feedback, Awareness and Behaviour in the Fenland Study
Scientific title
Acronym FAB
Serial number at source N/A
Study hypothesis Aim: To quantify the effect of measurement and feedback on physical activity behaviour

Measurement objectives:
1. Self awareness of physical activity levels
2. Effect of measurement on awareness
3. Effect of feedback on awareness and intentions
4. Effect of feedback on behaviour
5. Level of false reassurance
Ethics approval Full ethical approval received from Cambridgshire 2 Research Ethics Committee on 03/05/2007 (ref: 07/Q0108/79)
Study design Cohort study with randomisation to one of four different physical activity feedback groups (following participation in the Fenland Study)
Countries of recruitment United Kingdom
Disease/condition/study domain Physical activity behaviour
Participants - inclusion criteria 1. Aged 30-55 years
2. Registered with participating general practices in the Cambridgeshire Primary Care Trust
3. Participating in the Fenland Study
Participants - exclusion criteria 1. Have diagnosed diabetes
2. Have a terminal illness with a prognosis of less than 1 year
3. Suffer from psychotic illness
4. Are pregnant or lactating
5. Are unable to walk unaided
Anticipated start date 03/09/2007
Anticipated end date 03/06/2008
Status of trial Completed
Patient information material
Target number of participants 400 (100 per group)
Interventions The FAB Study has been set up as a nested cohort study within the Fenland Study, but with a very different purpose, and with separate ethical approval.

Volunteers in the Fenland Study have agreed to undergo oral glucose tolerance test and precise measurement of body anthropometry, body composition and physical activity over a one-week period (using individually calibrated Actihearts which measure heart rate and movement). Those who volunteer for FAB are randomly allocated to one of four groups:

Group 1: Control group - no feedback
Group 2: Physical activity feedback type A - Physical Activity Level (PAL)
Group 3: Physical activity feedback type B - PAL + daily heart rate and movement printouts
Group 4: Physical activity feedback type C - PAL + daily heart rate and movement printouts + goal setting and modelling information
Primary outcome measure(s) Objectively measured physical activity over 1 week (one month post-feedback), using a combined heart rate and movement sensor.
Secondary outcome measure(s) 1. Self-reported physical activity - RPAQ (baseline, and 1 month after feedback)
2. Self-rated physical activity (baseline, immediately after feedback, and 1 month after feedback)
3. Worry about own physical activity (baseline, immediately after feedback, and 1 month after feedback)
4. Physical activity outcome expectations (baseline, immediately after feedback, and 1 month after feedback)
5. Physical activity self-efficacy (baseline, immediately after feedback, and 1 month after feedback)
6. Intention to change physical activity (baseline, immediately after feedback, and 1 month after feedback)
7. Time orientation (baseline only)
Sources of funding Medical Research Council (UK)
Trial website
Publications
Contact name Dr  Simon  Griffin
  Address MRC Epidemiology Unit
Institute of Metabolic Science
Box 285
Addenbrooke's Hospital
Hills Road
  City/town Cambridge
  Zip/Postcode CB2 0QQ
  Country United Kingdom
  Tel +44 (0)1223 330 315
  Email simon.griffin@mrc-epid.cam.ac.uk
Sponsor Medical Research Council (UK)
  Address Medical Research Council Head OFfice
20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Email corporate@headoffice.mrc.ac.uk
Date applied 29/08/2007
Last edited 28/04/2008
Date ISRCTN assigned 11/09/2007
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central